152 related articles for article (PubMed ID: 18985556)
1. Prolonged neonatal complications after in utero exposure to fluoxetine.
Alehan F; Saygi S; Tarcan A; Gürakan B
J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
[TBL] [Abstract][Full Text] [Related]
2. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine withdrawal syndrome in the newborn.
Anbu AT; Theodore A
Indian Pediatr; 2006 Jan; 43(1):66-9. PubMed ID: 16465011
[TBL] [Abstract][Full Text] [Related]
4. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
Nordeng H; Lindemann R; Perminov KV; Reikvam A
Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine and neonatal withdrawal syndrome.
Pogliani L; Schneider L; Dilillo D; Penagini F; Zuccotti GV
BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736561
[TBL] [Abstract][Full Text] [Related]
6. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
[TBL] [Abstract][Full Text] [Related]
7. Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors.
Lavenstein B
JAMA; 2005 Nov; 294(18):2300; author reply 2300-1. PubMed ID: 16278356
[No Abstract] [Full Text] [Related]
8. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
[TBL] [Abstract][Full Text] [Related]
9. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
Koren G; Moretti M; Kapur B
J Obstet Gynaecol Can; 2006 Apr; 28(4):299-301. PubMed ID: 16776907
[TBL] [Abstract][Full Text] [Related]
10. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
Santos RP; Pergolizzi JJ
J Perinatol; 2004 Jun; 24(6):392-4. PubMed ID: 15167880
[TBL] [Abstract][Full Text] [Related]
11. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
[TBL] [Abstract][Full Text] [Related]
12. Neonatal toxicity following maternal citalopram treatment.
Eleftheriou G; Butera R; Cotti Cottini F; Bonati M; Farina M
Fetal Pediatr Pathol; 2013 Oct; 32(5):362-6. PubMed ID: 23438790
[TBL] [Abstract][Full Text] [Related]
13. Serotonin syndrome in a breast-fed neonate.
Morris R; Matthes J
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948853
[TBL] [Abstract][Full Text] [Related]
14. Perinatal outcome following third trimester exposure to paroxetine.
Costei AM; Kozer E; Ho T; Ito S; Koren G
Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
Klinger G; Merlob P
Isr J Psychiatry Relat Sci; 2008; 45(2):107-13. PubMed ID: 18982836
[TBL] [Abstract][Full Text] [Related]
16. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine during pregnancy: impact on fetal development.
Morrison JL; Riggs KW; Rurak DW
Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
[TBL] [Abstract][Full Text] [Related]
18. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
Koren G; Finkelstein Y; Matsui D; Berkovich M
J Obstet Gynaecol Can; 2009 Apr; 31(4):348-350. PubMed ID: 19497154
[No Abstract] [Full Text] [Related]
20. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
Laine K; Heikkinen T; Ekblad U; Kero P
Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
